• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Is Cannabis Bad for Cognition?

Is Cannabis Bad for Cognition?

November 1, 2018
Jessica Goren, PharmD, BCPP.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Jessica Goren, PharmD, BCPP. Dr. Goren has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Review of: Cobb SJ et al, JAMA Psychiatry 2018;75(6):585–595

Our patients typically tell us that, according to the internet, weed is perfectly safe and does not affect their ability to think or function. Thirty states and the District of Columbia have laws legalizing cannabis, supporting the notion that people have begun to think of marijuana as relatively harmless. Rates of marijuana use in young adults are rising (Hasin DS, Neuropsychopharmacology 2018;43(1):195–212). Moreover, a recent study reported that cannabidiol (CBD), a “non-psychoactive” component of marijuana, may reduce psychotic symptoms (Arain M et al, Neuropsychiatr Dis Treat 2013;9:449–461).

Given that the brain continues to develop into a person’s mid-20s, how dangerous is marijuana use in adolescence and young adulthood? And what do we tell our young patients who are regular users? A new meta-analysis attempts to answer part of that question as it relates to the impact of cannabis use on cognitive function in adolescents and young adults.

The meta-analysis assessed cognitive effects in young adults and adolescents whose primary clinical problem was cannabis use. The analysis included 69 studies of 2152 regular cannabis users and 6575 people with minimal use of cannabis. After combining the results from all of these studies, the authors concluded that cannabis does have a mild negative correlation with various aspects of cognition. Specifically, studies showed that use of the drug is negatively associated with executive functioning, speed of information processing, delayed memory, working memory, and attention. But in the aggregate, effect sizes range from -0.21 to -0.33, indicating minimal impact on cognition. Verbal language, visuospatial functioning, and motor functioning were relatively spared. Studies that required at least 72 hours of cannabis abstinence before testing reported no significant effect on cognitive function.

CCPR’s take
At first glance, these results may seem reassuring. Cognition was minimally impacted, and the effects did not extend beyond active use. However, many of the studies were small, measurement of cannabis use and potency varied, and significant publication bias was noted. Also, the meta-analysis focused solely on neurocognitive effects and ignored other clinically pertinent outcomes. A new study looking at 3826 seventh graders found neurotoxic effects of cannabis on memory and inhibitory control (Morin JG et al, Am J Psychiatry 2018 Oct 3:appiajp201818020202). Moreover, we have ample evidence that marijuana use is associated with poor academic and social function, that the tetrahydrocannabinol (THC) component of marijuana is associated with an overall doubling of psychosis risk in youth, and that this increased psychosis risk is dose-dependent. So however you interpret this analysis, THC is clearly not off the hook.
Child Psychiatry
KEYWORDS free_articles research-update substance_abuse
    Jessica Goren, PharmD, BCPP.

    Suicide Rates in College Students

    More from this author
    www.thecarlatreport.com
    Issue Date: November 1, 2018
    SUBSCRIBE NOW
    Table Of Contents
    Note From the Editor-in-Chief
    CME Post-Test - ADHD in Children and Adolescents, CCPR, November/December 2018
    Evaluating and Treating Co-Occurring ADHD and Bipolar Disorder
    Becoming Successful Despite ADHD
    Assessing and Treating Violence in Patients
    Is Cannabis Bad for Cognition?
    Jornay PM Nighttime Stimulant for Next-Morning Effect
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2432683359.jpg
      Child Psychiatry

      Hidden Dangers: The Fentanyl Crisis and Teen Overdose Prevention

      The Fentanyl overdose crisis is now one of the leading causes of death among adolescents, and it is happening in every corner of the country. Stay with us as we talk about the...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.